Symbiotec Pharmalab IPO has been subscribed 20.18 times so far on Day 3, led by robust demand from non-institutional investors (NIIs).
The ₹1,757-crore issue has received bids for 26.48 crore shares against 1.31 crore shares on offer. The NII portion has been subscribed 51.60 times, while the retail quota has seen 9.93 times subscription. The qualified institutional buyer (QIB) portion has been subscribed 14.65 times so far.
In the grey market, Symbiotec Pharmalab shares are commanding a premium of 29.05% over the IPO price.
Skyways Air Services IPO has also seen strong demand on the final day of bidding. The issue has been subscribed 22.93 times so far, with NIIs leading the subscription at 49.98 times. The retail portion has been subscribed 18 times, while the QIB quota has received 7.17 times subscription.
Shares of Skyways Air Services are commanding a 33.33% premium in the grey market today.
Hy-Tech Engineers IPO has attracted the strongest demand among the three issues, with the ₹136-crore offering subscribed 144.39 times so far, according to NSE data.
The issue has received bids for 261.99 crore shares against 1.81 crore shares on offer. The NII portion has been subscribed a massive 301.22 times, while retail investors have bid for 134.13 times the shares reserved for them. The QIB portion has been subscribed 39.58 times so far.
In the grey market, Hy-Tech Engineers shares are commanding a premium of 84.91% today.
Investors should note that grey market premiums are unofficial indicators of investor sentiment and can change rapidly before listing. They do not guarantee the actual listing price or returns.
